20 (AIDX) Long-Term Deferred Tax (2024 - 2025)
20 (AIDX) posted Long-Term Deferred Tax of $1.5 million for Q4 2025, up 57.21% on a QoQ basis from $959100.0 in Q4 2024, and up 57.21% year-over-year from $959100.0 in Q4 2024.
20 (AIDX) Long-Term Deferred Tax (2024 - 2025) Analysis & Trends
20's Long-Term Deferred Tax history runs 2 years deep, the most recent figure standing at $1.5 million for Q4 2025.
- Quarterly Long-Term Deferred Tax rose 57.21% year-over-year to $1.5 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $1.5 million (up 57.21% YoY) and the FY2025 annual result came in at $1.5 million, up 57.21% from the prior year.
- Long-Term Deferred Tax was $1.5 million for Q4 2025 at 20, up from $959100.0 in the prior quarter.
- Across five years, Long-Term Deferred Tax topped out at $1.5 million in Q4 2025 and bottomed at $959100.0 in Q4 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - |
| 10 | 20 | 3.91 Mn | -313,912.28 | 62,884.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 1.51 Mn |
| Dec 31, 2024 | 959,100.00 |